About
Mitochondrial protonophores
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
770
By Phase
PHASE2: 2PHASE1: 2
By Status
RECRUITING: 2ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06564584Lead Sponsor
Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD
PHASE2Recruiting
30 participants
Started: Aug 12, 2024 · Completed: Sep 30, 2025
NCT05822544Lead Sponsor
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
PHASE1Recruiting
564 participants
Started: Apr 22, 2023 · Completed: Dec 31, 2025
NCT05665751Lead Sponsor
A Study Evaluating Daily Oral Doses of TLC-3595 in Participants With Insulin Resistance
PHASE2Active, not recruiting
76 participants
Started: Mar 8, 2023 · Completed: Dec 31, 2024
NCT05483998Lead Sponsor
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
PHASE1Completed
100 participants
Started: Sep 9, 2022 · Completed: Jun 18, 2023
Locations (1)
Headquarters
Palo Alto, CA, United States
Map
Loading map...